The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells.
Oncotarget.
2022;13:46-60. doi: 10.18632/oncotarget.28169. eCollection 2022. PubMed PMID:
35018219; PubMed Central PMCID:
PMC8741193.
Regulation of a long noncoding RNA MALAT1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues.
Biochem Biophys Res Commun.
2020 Nov 19;532(4):563-569. doi: 10.1016/j.bbrc.2020.08.053. Epub 2020 Sep 6. PubMed PMID:
32900487; PubMed Central PMCID:
PMC7572814.
NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries.
FASEB J.
2019 Jul;33(7):8335-8348. doi: 10.1096/fj.201801881RR. Epub 2019 Apr 16. PubMed PMID:
30991008; PubMed Central PMCID:
PMC6593879.
Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer.
Sci Rep.
2017 Sep 6;7(1):10662. doi: 10.1038/s41598-017-11106-2. PubMed PMID:
28878246; PubMed Central PMCID:
PMC5587550.
Herbal Medicines for Inflammatory Diseases 2016.
Mediators Inflamm.
2016;2016:8270323. doi: 10.1155/2016/8270323. Epub 2016 Oct 25. PubMed PMID:
27847408; PubMed Central PMCID:
PMC5099452.
Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
Oncotarget.
2015 Sep 22;6(28):26359-72. doi: 10.18632/oncotarget.4560. PubMed PMID:
26317792; PubMed Central PMCID:
PMC4694907.
Deregulation of NR2E3, an orphan nuclear receptor, by benzo(a)pyrene-induced oxidative stress is associated with histone modification status change of the estrogen receptor gene promoter.
Toxicol Lett.
2015 Sep 17;237(3):228-36. doi: 10.1016/j.toxlet.2015.06.1708. Epub 2015 Jul 3. PubMed PMID:
26149760; PubMed Central PMCID:
PMC4524348.
Herbal medicines for inflammatory diseases.
Mediators Inflamm.
2014;2014:982635. doi: 10.1155/2014/982635. Epub 2014 Dec 24. PubMed PMID:
25609893; PubMed Central PMCID:
PMC4290032.
The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis.
Neoplasia.
2014 Dec;16(12):1059-69. doi: 10.1016/j.neo.2014.09.011. PubMed PMID:
25499219; PubMed Central PMCID:
PMC4309261.
Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
Mol Cell Biol.
2014 Jul;34(13):2382-95. doi: 10.1128/MCB.01602-13. Epub 2014 Apr 14. PubMed PMID:
24732804; PubMed Central PMCID:
PMC4054319.
MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression.
Mol Cancer Ther.
2014 Jul;13(7):1942-51. doi: 10.1158/1535-7163.MCT-13-1000. Epub 2014 Apr 30. PubMed PMID:
24785257; PubMed Central PMCID:
PMC4090280.
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer.
Oncogene.
2013 Mar 28;32(13):1616-25. doi: 10.1038/onc.2012.193. Epub 2012 May 21. PubMed PMID:
22614017; PubMed Central PMCID:
PMC3484248.
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
Int J Cancer.
2013 Feb 15;132(4):795-806. doi: 10.1002/ijc.27730. Epub 2012 Aug 3. PubMed PMID:
22815231; PubMed Central PMCID:
PMC3527649.
Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
BMC Cancer.
2012 Nov 30;12:564. doi: 10.1186/1471-2407-12-564. PubMed PMID:
23194063; PubMed Central PMCID:
PMC3522018.
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
Carcinogenesis.
2012 Oct;33(10):1843-53. doi: 10.1093/carcin/bgs167. Epub 2012 May 10. PubMed PMID:
22581827; PubMed Central PMCID:
PMC3529559.
Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
Mol Cancer Ther.
2012 Sep;11(9):1852-62. doi: 10.1158/1535-7163.MCT-12-0181. Epub 2012 Jun 29. PubMed PMID:
22752225; PubMed Central PMCID:
PMC3632183.
The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.
Oncogene.
2012 Jul 5;31(27):3265-76. doi: 10.1038/onc.2011.504. Epub 2011 Nov 14. PubMed PMID:
22081070; PubMed Central PMCID:
PMC3299891.
Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Mol Cancer Ther.
2012 Jul;11(7):1421-31. doi: 10.1158/1535-7163.MCT-12-0026. Epub 2012 May 2. PubMed PMID:
22553354; PubMed Central PMCID:
PMC4924623.
Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer.
Oncogene.
2012 Feb 23;31(8):1034-44. doi: 10.1038/onc.2011.296. Epub 2011 Jul 18. PubMed PMID:
21765466; PubMed Central PMCID:
PMC3288192.
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
EMBO Mol Med.
2012 Jan;4(1):52-67. doi: 10.1002/emmm.201100187. Epub 2011 Dec 15. PubMed PMID:
22174013; PubMed Central PMCID:
PMC3376834.
Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
Mol Cancer Ther.
2012 Jan;11(1):108-18. doi: 10.1158/1535-7163.MCT-11-0548. Epub 2011 Oct 27. PubMed PMID:
22034498; PubMed Central PMCID:
PMC3256275.
Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.
PLoS One.
2011;6(9):e24662. doi: 10.1371/journal.pone.0024662. Epub 2011 Sep 9. PubMed PMID:
21931799; PubMed Central PMCID:
PMC3170379.
Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.
Carcinogenesis.
2011 Jun;32(6):836-42. doi: 10.1093/carcin/bgr040. Epub 2011 Mar 1. PubMed PMID:
21362629; PubMed Central PMCID:
PMC3106434.
MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.
J Mol Endocrinol.
2011 Apr;46(2):67-79. doi: 10.1677/JME-10-0110. Print 2011 Apr. PubMed PMID:
21169420; PubMed Central PMCID:
PMC3069690.
Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
Cancer Res.
2010 Sep 1;70(17):6824-36. doi: 10.1158/0008-5472.CAN-10-1992. Epub 2010 Jul 21. PubMed PMID:
20660371; PubMed Central PMCID:
PMC2988472.
MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
Endocrinology.
2010 Jun;151(6):2462-73. doi: 10.1210/en.2009-1150. Epub 2010 Apr 9. PubMed PMID:
20382698; PubMed Central PMCID:
PMC2875816.
In vivo profiling of estrogen receptor/specificity protein-dependent transactivation.
Endocrinology.
2008 Nov;149(11):5696-705. doi: 10.1210/en.2008-0720. Epub 2008 Jul 17. PubMed PMID:
18635651; PubMed Central PMCID:
PMC2584598.
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.
J Mol Endocrinol.
2008 Nov;41(5):263-75. doi: 10.1677/JME-08-0103. Epub 2008 Sep 4. Review. PubMed PMID:
18772268; PubMed Central PMCID:
PMC2582054.
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.
Science.
2007 Jul 6;317(5834):121-4. doi: 10.1126/science.1140485. PubMed PMID:
17615358.
Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
Mol Endocrinol.
2006 Sep;20(9):2199-214. doi: 10.1210/me.2006-0100. Epub 2006 May 4. PubMed PMID:
16675542.
3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha.
Cancer Res.
2006 Feb 15;66(4):2459-67. doi: 10.1158/0008-5472.CAN-05-3132. PubMed PMID:
16489053.
Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer.
Mol Endocrinol.
2005 Apr;19(4):843-54. doi: 10.1210/me.2004-0326. Epub 2005 Jan 6. PubMed PMID:
15637147.
DRIP150 coactivation of estrogen receptor alpha in ZR-75 breast cancer cells is independent of LXXLL motifs.
J Biol Chem.
2005 Mar 11;280(10):8819-30. doi: 10.1074/jbc.M413184200. Epub 2004 Dec 28. PubMed PMID:
15625066.
Nuclear receptor-mediated transactivation through interaction with Sp proteins.
Prog Nucleic Acid Res Mol Biol.
2004;77:1-36. doi: 10.1016/S0079-6603(04)77001-4. Review. PubMed PMID:
15196889.
Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Mol Endocrinol.
2003 May;17(5):804-17. doi: 10.1210/me.2002-0406. Epub 2003 Feb 6. PubMed PMID:
12576490.
Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists.
J Mol Endocrinol.
2001 Feb;26(1):31-42. doi: 10.1677/jme.0.0260031. PubMed PMID:
11174852.
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols.
Carcinogenesis.
1998 Apr;19(4):611-6. doi: 10.1093/carcin/19.4.611. PubMed PMID:
9600345.
What would you like to do?